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Abstract
Microvascular alterations can parallel and even precede development of cardiovascular disease. Ocular bulb, due to 
transparent anatomical elements provides a unique opportunity to examine microcirculation non-invasively and in 
vivo by means of scanning laser Doppler flowmetry. This device enables to obtain both structural and functional 
parameters of retinal microvasculature. Alterations observed in retinal arterioles, i.e. lumen narrowing, increased 
wall-to-lumen ratio, rarefaction or reduced retinal capillary flow, have been independently associated with cardi-
ometabolic diseases: hypertension, heart failure, coronary artery disease, stroke, chronic kidney disease and diabetes. 
Therefore, examination of easily accessible retinal microcirculation may provide novel insights into the mechanisms 
underlying various diseases, serve as a marker of target organ damage and add valuable information to cardiovascular 
risk stratification.
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Introduction
Cardiovascular diseases remain the most important 
cause of mortality worldwide [1] despite an im-
pressive development of novel treatment strategies. 
Substantial proportion of cardiovascular events can 
only partially be explained by typical risk factors. 
Therefore, we should constantly focus on studying 
new biomarkers that would enable more accurate 
risk stratification and earlier therapeutic interven-
tions [2].
Circulatory system consists of three inseparable 
components: micro-, macrocirculation and the heart. 
These three interrelated districts influence structure 
and function of each other, regulating hemodynamics 
of circulatory system [3, 4]. 
Coupling between  
microcirculation-macrocirculation-the heart
To understand the coupling between vascular tree 
and the heart, we propose the following diagram 
(partially based on diagram created by Laurent S. 
and Agabiti-Rosei E. [5]), demonstrating consecutive 
cardiovascular changes occurring in hypertension:
In small arteries, alterations in essential hyper-
tension correspond to increased wall thickness, de-
creased lumen diameter and increased wall-to-lumen 
ratio without any change in total wall material and 
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were called by Mulvany et al. in 1996 as eutrophic in-
ward remodeling [6]. These changes are major deter-
minants raising total peripheral resistance and mean 
blood pressure. In consequence, stiff components 
load in vessel wall, exaggerating arterial stiffening 
and premature wave reflection which, arriving in late 
systole, augments central systolic and pulse pressures 
[7]. Importantly, as aortic stiffness increases, stiffness 
gradient decreases leading to the shift of reflection 
sites toward microvessels [8]. This contributes to 
the penetration of excessive pressure pulsatility into 
microcirculation and then to small artery remodeling 
and damage [9]. 
Moreover, increased central systolic BP contrib-
utes to greater left ventricular afterload, and con-
sequent myocardial hypertrophy and increased 
myocardial oxygen demand [10]. Elevated values of 
PP and decreased DBP are related to diminished 
coronary arteries perfusion during diastole thereby 
leading to myocardial ischemia. Additionally, chroni-
cally elevated blood pressures result in microvascu-
lar remodeling and vasoconstriction that may also 
impair vasodilatory reserve and lead to myocardial 
hypoperfusion [10].
Myocardial hypertrophy accompanied by inten-
sive fibrosis augments LV filling pressures that pre-
cede atrial and ventricular enlargement and further 
diastolic and systolic dysfunction. Subsequent in-
creased activity of vasoactive neurohormonal sys-
tems such as sympathetic nervous system or renin-
angiotensin-aldosterone system — on the one hand 
preserve circulatory homeostasis, on the other hand 
promote inflammation processes, endothelial dys-
function and further vascular remodeling [11, 12].
The microvasculature of the eye
Previous studies have shown that changes in micro-
circulation can parallel [13, 14] and even precede 
cardiovascular diseases [15]. Therefore, the micro-
vascular area appears to be a valuable tool to assess 
cardiovascular risk especially at asymptomatic stage 
of disease. 
Figure 1. Coupling between microcirculation, macrocirculation and the heart. LV — left ventricular; MBP — mean blood pressure; 
PP — pulse pressure; RAAS — renin–angiotensin–aldosterone system; SBP — systolic blood pressure 
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Microcirculation — anatomy
Microcirculation is a part of the circulatory system 
localized between the arterial and venous system. It 
includes vessels with a diameter less than 150 μm: 
arterioles, metaarterioles, capillaries, venules, lym-
phatic vessels and arteriovenous anastomoses. The 
peripheral circulation of the whole body consists of 
10 billion capillaries with a total surface approxi-
mately 500–700 square meters. [16].
Microcirculation — role in total peripheral 
resistance
Poiseuille’s law states that vascular resistance (R) is di-
rectly proportional to the length (L) of the vessel and 
the viscosity (h) of the blood, and inversely propor-
tional to the fourth power of the vessel radius to (r4):
R = (8Lh)/πr2
According to this equation and taking into ac-
count the huge number of microvessels in the whole 
body and microvascular inward remodeling described 
by Mulvany et al., we may easily infer that microcir-
culation is the pivotal modulator of total peripheral 
resistance. It is worth noting that different types of 
remodeling, i.e. hypertrophic, eutrophic or hypotro-
phic, are observed in various diseases. Additionally, 
remodeling can be inward or outward.
Microcirculation of retina — measurement 
of structure and function
From all microvascular beds, retinal microcirculation 
due to transparent anatomical elements of ocular 
bulb, provides a unique opportunity to be examined 
non-invasively and in vivo. Scanning laser Doppler 
flowmetry allows evaluating both structure and func-
tion of microcirculation. The examination is per-
formed in a dark room, in a sitting position, after 
15 min of rest, without any pharmacological pupil 
dilatation. Measurements are taken in juxtapapillary 
area of the right eye, 2–3 mm temporally superior 
to the optic nerve. The retinal sample of 2.56 × 0.64 
× 0.3 mm at a resolution of 256 points × 64 lines 
× 128 lines is scanned within 2 seconds [17]. 
Retina is illuminated by laser light (of 670 
nm wavelength), which scattered by moving red 
blood cells is shifted in frequency by an amount 
Δf — shown in equation 1:
Δf: (1/2π) (ksc - ki) v
where ksc is the wave vector of the scattered light, 
ki is the wave vector of the incident light and v is the 
velocity vector of the moving particle. The laser beam 
hits moving blood cells and the spectrum broadens. 
The collected light is guided to a photodetector and 
then analyzed. 
The effective Doppler shift, called flow is calcu-
lated in equation 2:
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where fP(f )df  is the power of the photodetector 
associated with fluctuations in a frequency range 
df about f and P(f = 0) is the power in the detected 
signal. Flow describes total distance travelled by the 
moving red blood cells per unit time within the 
sample volume [18].
Perfusion map is obtained from images by means 
of Automatic Full Field Analysis of Perfusion 
(AFFPIA) [17].
The following structural parameters of retinal arte-
rioles are evaluated: outer diameter (OD) is assessed 
in reflection images, and the lumen diameter (LD) is 
assessed in perfusion images [17]. 
Wall thickness (WT) is calculated using the for-
mula: 
WT = OD – LD/2
Wall cross-sectional area (WCSA) is calculated 
using the formula: 
WCSA = (π/4) × (OD2 – LD2)
WLR is calculated using the formula: 
WLR= (OD – LD)/LD
Microvascular retinal alterations 
in cardiovascular diseases
Hypertension
In the study of Smith et al., generalized retinal ar-
teriolar narrowing was significantly associated with 
subsequent 5-year incident severe hypertension, in-
dependent  of cardiovascular risk factors and base-
line blood pressure status [19]. Also increased value 
of retinal arteriolar wall-to-lumen ratio was widely 
revealed as a hallmark of hypertension [20]. Apart 
from structural microvascular changes, retinal capil-
lary blood flow (RCF) was found to be significantly 
reduced in hypertension. Ritt et al. have reported 
that in response to flicker light, the increase of RCF 
was significantly lower in hypertensive patients than 
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in normotensive subjects, identifying a reduced va-
sodilatatory properties and risk of tissue hypoperfu-
sion in hypertension [21]. Moreover, it was recently 
shown that RCF significantly decreases with hyper-
tension advancement expressed by elevated value of 
pulse wave velocity [22]. 
Heart diseases
Wong et al. have reported in a population-based 
cohort study including 11612 participants that the 
presence of retinopathy was associated with signifi-
cantly higher incidence of congestive heart failure 
(15.1% in subjects with retinopathy vs 4.8% in 
subjects without retinopathy (p < .001). After ad-
justment for typical cardiovascular risk factors, the 
presence of retinopathy was associated with even 
2-fold higher risk of congestive heart failure in 7-year 
observation [15]. The recent investigations have also 
reported that lumen narrowing of retinal vessels is 
independently associated with left atrium enlarge-
ment and left ventricular mass — the antecedents of 
diastolic dysfunction and heart failure [13]. 
In the study of Wang et al., the narrower retinal 
arterioles were related to lower hyperemic myocardial 
blood flow and lower perfusion reserve evaluated by 
cardiac magnetic resonance in asymptomatic patients 
with no coronary calcification. These results revealed 
that retinal changes may serve as a marker of coro-
nary microvascular disease [23].
Stroke
The main finding of the study of Harazny et al. was 
the evidence of retinal hypertrophic remodeling in 
hypertensive patients with cerebrovascular event. In 
this group, microvascular changes were expressed 
by significant decrease in lumen diameter, increase 
in wall cross sectional area and wall-to-lumen ratio 
compared to normotensive subjects [14]. In the in-
vestigation of Lindley et al., patients with lacunar 
stroke were more likely to have changes in retinal 
microvasculature, such as focal arteriolar narrowing, 
arteriovenous nipping, enhanced light reflex of the 
arteriolar wall, generalized retinal arteriolar narrow-
ing, small arteriole:venule ratio and retinal venular 
widening [24].
Microvascular retinal alterations in 
other diseases
Chronic kidney disease
Patients with chronic kidney disease have greater 
wall thickness and greater wall-to-lumen ratio of 
retinal arterioles in comparison to healthy indi-
viduals. Moreover, intercapillary distance reflect-
ing capillary rarefaction was significantly greater in 
the chronic kidney disease group compared to the 
healthy control group. After adjustment for age, 
gender, BMI and serum cholesterol, wall thickness, 
wall cross sectional area, wall-to-lumen ratio and 
intercapillary distance remained significantly higher 
in chronic kidney disease group [25]. Furthermore, 
Ritt et al. have demonstrated that retinal remodel-
ing was related to microalbuminuria – the marker 
of impaired renal function and well established risk 
factor for cardiovascular mortality and morbidity. 
The results of the study have revealed that wall-
to-lumen ratio of retinal arterioles was positively 
related to urinary albumin-to-creatinine ratio [26]. 
Moreover, the investigation of Sabanayagam et al., 
carried out in a large multiethnic population, has 
shown a close relationship between the presence 
of retinal arteriolar narrowing and the increased 
likelihood of chronic kidney disease defined by 
an estimated glomerular filtration rate less than 
60 mL/min per 1.73 m2 [27].
Diabetes
In the prospective study of adult Australians, nar-
rower retinal arterioles were associated with increased 
incidence of diabetes, independently of fasting plas-
ma glucose, systolic blood pressure, family history of 
diabetes, waist circumference, and other confound-
ing factors. These findings indicate that early micro-
vascular alterations may underlie the development of 
diabetes and serve as a subclinical marker of diabetes 
risk [28]. Moreover, in the study of Jumar et al., 
diabetes was linked to a greater retinal arteriolar 
wall thickness and wall cross sectional area than in 
hypertensive or healthy subjects indicating for hyper-
trophic remodeling [29].
Conclusions
Retinal circulation provides a window to other mi-
crovascular beds. Its complex evaluation appears to 
be a valuable tool to better understand mechanisms 
underlying cardiometabolic diseases and to assess 
development and progression of vascular damage. 
Identification of asymptomatic subjects with altered 
retinal microcirculation might provide an opportu-
nity for early therapeutic intervention. Thus, extend-
ing the list of typical diagnostic tools with the new 
microvascular parameters could allow more precise 
assessment of subclinical target organ damage, and 
improve prevention and treatment of cardiovascular 
diseases.
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